Conference Coverage

Is Parkinson’s Disease a Prion Disorder?


 

Erik Greb
Senior Associate Editor

Suggested Reading

Bae EJ, Lee HJ, Rockenstein E, et al. Antibody-aided clearance of extracellular a-synuclein prevents cell-to-cell aggregate transmission. J Neurosci. 2012;32(39):13454-13469.

Luk KC, Kehm V, Carroll J, et al. Pathological a-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science. 2012;338(6109):949-953.

Olanow CW, Brundin P. Parkinson’s disease and alpha synuclein: is Parkinson’s disease a prion-like disorder? Mov Disord. 2013;28(1):31-40.

Pages

Recommended Reading

Deep brain stimulation might help early in Parkinson's
MDedge Neurology
Parkinson's symptoms improved in new drug trials
MDedge Neurology
Parkinson's medication aids did not improve adherence
MDedge Neurology
REM sleep problems predict Parkinson's, Lewy body dementia
MDedge Neurology
Fabrizio Benedetti, MD, Discusses Placebo Responses and How Therapeutic Rituals Affect the Brain
MDedge Neurology
Study Provides Clinical Picture of Patients With Parkinson's Disease at 10 Years
MDedge Neurology
How Can Physicians Reduce the Risks Associated With Compounded Intrathecal Medications?
MDedge Neurology
Full-Scale IQ and List Learning May Predict Cognitive Change After DBS
MDedge Neurology
Deep Brain Stimulation Might Help Patients During Early Parkinson's Disease
MDedge Neurology
New and Noteworthy Information—April 2013
MDedge Neurology